discover voltaren emulgel

Members of: Marketing Code Authority: info@marketingcode.co.za, Tel. No. +27 63 044 5200. South African Health Products Regulatory Authority Tel. No. +27 12 501 0300 Email: enquiries@sahpra.org.za

*We do not supply our products directly to consumers. By selecting the Buy Now button on this page, you will be re-directed to a list of retailers’ websites for purchase. Kindly note that purchase will be subject to stock availability

Promotion of Access to Information Act (PAIA)

The PAIA manual is prepared in accordance with section 51 of the Promotion of Access to Information Act (PAIA) No. 2 of 2000 (as amended) and the Protection of Personal Information Act, 2013. The purpose of PAIA is to promote the right of access to information, to foster a culture of transparency and accountability within the Company by giving the right to information that is required for the exercise or protection of any right and to actively promote a society in which the people of South Africa have effective access to information to enable them to exercise and protect their rights.

Please see the PAIA manual.

Applicant: GlaxoSmithKline Consumer Healthcare SA (Pty) Ltd, Company Reg. No. 2014/173930/07. Hawkins Avenue, Epping Industria 1, 7460. Tel. No. +27 0800 118 274.

S0 20 g & 50 g S1 100 g Voltaren Emulgel. Each 100 g contains 1.16 g diclofenac diethylamine corresponding to 1 g diclofenac sodium Reg. no.: U/3.1/77. Botswana: S3 Reg. no.: B9305535. Namibia: NS1 Reg. no.04/3.1/0344. Indicated for use in adults and adolescents older than 12 years. Safety in pregnancy and lactation has not been established. Consult your pharmacist/ healthcare professional if needed.

S1 Voltaren Emulgel 12 Hour. 1 g of Voltaren Emulgel 12 Hour contains, 23,2 mg of the active substance diclofenac diethylamine, which corresponds to 20 mg diclofenac sodium. Reg.No.: 46/3.1/0649. Indicated for use in adults and adolescents older than 14 years. Safety in pregnancy and lactation has not been established. Consult your pharmacist/ healthcare professional if needed.

GlaxoSmithKline Consumer Healthcare South Africa (Pty) Ltd. 39 Hawkins Avenue, Epping Industria 1, Cape Town, 7460. Reg. No: 2014/173930/07.

For full prescribing information refer to the professional information approved by the medicines regulatory authority.

For any further information, including safety, please contact the GSK Hotline on +27 11 745 6001 or 0800 007 018.

Trademarks are owned by or licensed to Haleon group of companies.

Always read the label before use

Consumer safety is always of the highest priority in GSK Consumer Health. Reports relating to safety are investigated and reported to the authorities by GSK as appropriate. Always use this product in accordance with the labelled instructions. To report an adverse event or complaint, please contact Haleon on 0800 007 018 or mystory@haleon.com

©2023 GlaxoSmithKline Consumer Healthcare
This website is intended for South Africa residents only. Trade marks are registered to Haleon group of Companies.

PM-ZA-VOLT-23-00009

PM-ZA-VOLT-23-00010

PM-ZA-VOLT-23-00011

PM-ZA-VOLT-23-00012